Hypoglycaemia

Cards (11)

  • hypoglycaemia is a blood glucose concentration less than 4 mmol/L
  • Symptoms:
    ·       Feeling hungry- first sign
    ·       Sweating
    ·       Dizziness
    ·       Fatigue
    ·       Burred vision
    ·       Palpitations
    ·       Trembling or shakiness
    ·       Escalation of symptoms if untreated- confusion and reduced GCS
  • Any patient with a blood-glucose concentration less than 4 mmol/litre, with or without symptoms, and who is conscious and able to swallow, should be treated with a fast-acting carbohydrate by mouth
  • Fast acting carbohydrates:
    • Glucojuice
    • Glucose tablets
    • Glucose gels
    • Pure fruit juice
    • Sugar dissolved in water
  • If necessary, repeat treatment after 15 minutes, up to a maximum of 3 treatments in total. Once blood-glucose concentration is above 4 mmol/litre and the patient has recovered, a snack providing a long-acting carbohydrate should be given to prevent blood glucose from falling again (e.g. two biscuits, one slice of bread)
  • Hypoglycaemia which does not respond (blood-glucose concentration remains below 4 mmol/litre after 30–45 minutes or after 3 treatment cycles), should be treated with intramuscular glucagon or glucose 10% intravenous infusion.
  • In alcoholic patients, thiamine supplementation should be given with, or following, the administration of intravenous glucose to minimise the risk of Wernicke's encephalopathy.
  • In an emergency, if the patient has a decreased level of consciousness caused by hypoglycaemia, intramuscular glucagon can be given by a family member or friend who has been shown how to use it. If glucagon is not effective after 10 minutes, glucose 10% intravenous infusion should be given.
  • Hypoglycaemia with unconsciousness, seizures or aggression:
    • Stop any IV insulin
    • Treat initially with IM glucagon
    • If no response after 10 mins, give 10% glucose infusion
    • Give long acting carbohydrate as soon as able to eat
  • If an insulin injection is due, it should not be omitted; however, a review of the usual insulin regimen may be required.
  • Blood-glucose monitoring should be continued for at least 24–48 hours